Drug reduces risk of prostate cancer diagnosis in high-risk men

Drug reduces risk of prostate cancer diagnosis in high-risk men
A drug already prescribed to shrink benign, enlarged prostates has been shown to reduce the risk of a prostate cancer diagnosis by 23 percent in men with an increased risk of the disease, a large international trial has found. The four-year study found that dutasteride (Avodart) significantly reduced the chances that men would be diagnosed with the kinds of tumors that are most often treated …

Read more on Science Daily

Additional reading:

1. Reducing The Risk Of Prostate Cancer Diagnosis In High-Risk Men
   
   Reducing The Risk Of Prostate Cancer Diagnosis In High-Risk Men A drug already prescribed to shrink benign, enlarged prostates has been shown to reduce the risk of a prostate cancer diagnosis by 23 percent in men with...


2. International, four-year study finds dutasteride reduces risk of prostate cancer diagnosis in men
   
   International, four-year study finds dutasteride reduces risk of prostate cancer diagnosis in men A drug already prescribed to shrink benign, enlarged prostates has been shown to reduce the risk of a prostate cancer diagnosis by 23 percent...